<DOC>
	<DOCNO>NCT00844415</DOCNO>
	<brief_summary>To investigate safety tolerability dabigatran etexilate capsule small group eight adolescent patient .</brief_summary>
	<brief_title>Safety Tolerability Dabigatran Etexilate Adolescents</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Dabigatran</mesh_term>
	<criteria>Inclusion criterion : 1. male females 12 less 18 year age 2. objective diagnosis primary VTE 3. completion plan treatment course LMWH OAC primary VTE 4. write informed consent parent ( legal guardian ) patient assent Exclusion criterion : 1. weight less 32 kg 2. condition associate increase risk bleed 3. severe renal dysfunction requirement dialysis 4. active infective endocarditis 5. hepatic disease 6. pregnant female female use medically accept contraceptive method 7. anemia thrombocytopenia 8. use prohibit restricted drug within previous week 9. receive investigational drug within past 30 day 10. unreliable patient patient condition would allow safe participation study</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>